Evidence map›Paper›PMID 30075061›Full record

ReviewJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2018

The Spectrum of Fundamental Basic Science Discoveries Contributing to Organismal Aging.

Joshua N Farr, Maria Almeida

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Phenylethanoid Glycosides fromInternational journal of molecular sciences · 2026
    Article
  4. Review
  5. Article
  6. Emerging basic science concepts in geriatric fracture fixation and patient recovery.OTA international : the open access journal of orthopaedic trauma · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Skeletal Senescence with Aging and Type 2 Diabetes.Endocrinology and metabolism (Seoul, Korea) · 2023
    Article
  13. Review
  14. Article
  15. Review
  16. Multimorbidity.Nature reviews. Disease primers · 2022
    Review
  17. Article
  18. Skeletal Aging.Mayo Clinic proceedings · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Joshua N FarrDivision of Endocrinology and Metabolism and Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
Maria AlmeidaDivision of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
University of Arkansas for Medical Sciences · USWinnMed · US

Funding

TRANSGENIC MOUSE COREP01AG013918 · NIA · UNIV OF ARKANSAS FOR MED SCIS · PI MANOLAGAS, STAVROS C. · 1996 to 2016
$25.7M
Understanding the Negative Prognostic Impact of Intraosseous Focal Lesions in Multiple MyelomaP20GM125503 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Sanja Novak · 2018 to 2026
$23.0M
Role of FoxOs in Skeletal Homeostasis- ResubmissionR01AR056679 · NIAMS · UNIV OF ARKANSAS FOR MED SCIS · PI ALMEIDA, MARIA JOSE · 2010 to 2020
$3.6M
The Role of Cellular Senescence in Mediating Age-Related Bone LossK01AR070241 · NIAMS · MAYO CLINIC ROCHESTER · PI FARR, JOSHUA NICHOLAS · 2016 to 2020
$640k
NIAMS NIH HHS K01 AR070241NIAMS NIH HHS R01 AR056679NIA NIH HHS P01 AG013918NIGMS NIH HHS P20 GM125503
6 · The paper itself

Abstract

Aging research has undergone unprecedented advances at an accelerating rate in recent years, leading to excitement in the field as well as opportunities for imagination and innovation. Novel insights indicate that, rather than resulting from a preprogrammed series of events, the aging process is predominantly driven by fundamental non-adaptive mechanisms that are interconnected, linked, and overlap. To varying degrees, these mechanisms also manifest with aging in bone where they cause skeletal fragility. Because these mechanisms of aging can be manipulated, it might be possible to slow, delay, or alleviate multiple age-related diseases and their complications by targeting conserved genetic signaling pathways, controlled functional networks, and basic biochemical processes. Indeed, findings in various mammalian species suggest that targeting fundamental aging mechanisms (eg, via either loss-of-function or gain-of-function mutations or administration of pharmacological therapies) can extend healthspan; ie, the healthy period of life free of chronic diseases. In this review, we summarize the evidence supporting the role of the spectrum of fundamental basic science discoveries contributing to organismal aging, with emphasis on mammalian studies and in particular aging mechanisms in bone that drive skeletal fragility. These mechanisms or aging hallmarks include: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. Because these mechanisms are linked, interventions that ameliorate one hallmark can in theory ameliorate others. In the field of bone and mineral research, current challenges include defining the relative contributions of each aging hallmark to the natural skeletal aging process, better understanding the complex interconnections among the hallmarks, and identifying the most effective therapeutic strategies to safely target multiple hallmarks. Based on their interconnections, it may be feasible to simultaneously interfere with several fundamental aging mechanisms to alleviate a wide spectrum of age-related chronic diseases, including osteoporosis. © 2018 American Society for Bone and Mineral Research.

Indexed as

Biomedical ResearchAgingAnimalsEpigenesis, GeneticGenomic InstabilityHumansProteostasisTelomereAGINGBONEDISEASE PREVENTIONOSTEOPOROSIS

Identifiers

PMID30075061
PMCPMC6327947
OpenAlexW2886661663

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.